文献速递胸部技术与安全CT

B细胞耗竭治疗后的B细胞淋巴瘤患者迁延性SARS-CoV-2感染中的迁移性肺炎

Migratory Pneumonia in Prolonged SARS-CoV-2 Infection in Patients Treated With B-cell Depletion Therapies for B-cell Lymphoma.
PubMed 文献 · Korean J Radiol · 2023-02-16

本研究回顾性分析7例接受B细胞耗竭化疗的B细胞淋巴瘤患者,在COVID-19后系列胸部CT上表现为迁移性磨玻璃影和实变,并伴有持续症状和PCR阳性。结论提示此类患者系列CT上的迁移性气腔 opacity 可解释为持续性COVID-19肺炎。

要点

  • B细胞淋巴瘤患者接受利妥昔单抗等B细胞耗竭治疗后,COVID-19可表现为迁延性感染。
  • 系列胸部CT可见原有气腔病变清除,同时出现新部位的外周及支气管周围GGO和实变。
  • 持续症状伴鼻咽拭子PCR阳性(Ct值<25)提示持续病毒复制,需结合系列CT评估。

关键影像表现/征象

  • 基线CT均显示多灶性斑片状外周磨玻璃影(GGO),以下叶为主。
  • 随访CT显示原有气腔病变清除,同时在不同部位新出现外周和支气管周围GGO及实变。
  • 随访期间中位CT扫描3次(中位随访124天),所有患者持续COVID-19症状伴鼻咽拭子PCR阳性(Ct值<25)。

临床应用与阅片要点

  • 对接受B细胞耗竭治疗的淋巴瘤患者,若COVID-19症状持续,应行系列胸部CT动态观察。
  • 系列CT上出现迁移性气腔 opacity 时,应结合PCR结果考虑持续性COVID-19肺炎,而非新发感染或其他间质性肺炎。
  • 注意与机化性肺炎、药物性肺损伤等鉴别,持续病毒学检测有助于确认。

局限性

  • 回顾性单中心研究,样本量小(7例)。
  • 仅纳入系列CT显示迁移性气腔 opacity 的患者,存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To report the clinical and radiological characteristics of patients with underlying B-cell lymphoma and coronavirus disease 2019 (COVID-19) showing migratory airspace opacities on serial chest computed tomography (CT) with persistent COVID-19 symptoms.

MATERIALS AND METHODS: From January 2020 to June 2022, of the 56 patients with underlying hematologic malignancy who had undergone chest CT more than once at our hospital after acquiring COVID-19, seven adult patients (5 female; age range, 37-71 years; median age, 45 years) who showed migratory airspace opacities on chest CT were selected for the analysis of clinical and CT features.

RESULTS: All patients had been diagnosed with B-cell lymphoma (three diffuse large B-cell lymphoma and four follicular lymphoma) and had received B-cell depleting chemotherapy, including rituximab, within three months prior to COVID-19 diagnosis. The patients underwent a median of 3 CT scans during the follow-up period (median 124 days). All patients showed multifocal patchy peripheral ground glass opacities (GGOs) with basal predominance in the baseline CTs. In all patients, follow-up CTs demonstrated clearing of previous airspace opacities with the development of new peripheral and peribronchial GGO and consolidation in different locations. Throughout the follow-up period, all patients demonstrated prolonged COVID-19 symptoms accompanied by positive polymerase chain reaction results from nasopharyngeal swabs, with cycle threshold values of less than 25.

CONCLUSION: COVID-19 patients with B-cell lymphoma who had received B-cell depleting therapy and are experiencing prolonged SARS-CoV-2 infection and persistent symptoms may demonstrate migratory airspace opacities on serial CT, which could be interpreted as ongoing COVID-19 pneumonia.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Lee, Lee, Beck, et al. Migratory Pneumonia in Prolonged SARS-CoV-2 Infection in Patients Treated With B-cell Depletion Therapies for B-cell Lymphoma. Korean J Radiol. 2023. PMID: 36907590. doi:10.3348/kjr.2022.0844

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。